BlackRock Fund Advisors’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $44.4M | Buy |
2,133,222
+278,278
| +15% | +$5.79M | 0.01% | 1759 |
|
|
2016
Q3 | $60.8M | Buy |
1,854,944
+100,431
| +6% | +$3.29M | 0.01% | 1439 |
|
|
2016
Q2 | $43.8M | Buy |
1,754,513
+617,690
| +54% | +$15.4M | 0.01% | 1581 |
|
|
2016
Q1 | $27.8M | Buy |
1,136,823
+45,908
| +4% | +$1.12M | 0.01% | 1795 |
|
|
2015
Q4 | $36M | Sell |
1,090,915
-82,739
| -7% | -$2.73M | 0.01% | 1701 |
|
|
2015
Q3 | $38.4M | Buy |
1,173,654
+195,017
| +20% | +$6.39M | 0.01% | 1589 |
|
|
2015
Q2 | $51.8M | Buy |
978,637
+224,075
| +30% | +$11.9M | 0.01% | 1506 |
|
|
2015
Q1 | $21.8M | Buy |
754,562
+170,980
| +29% | +$4.93M | 0.01% | 2025 |
|
|
2014
Q4 | $17M | Buy |
583,582
+394,513
| +209% | +$11.5M | ﹤0.01% | 2159 |
|
|
2014
Q3 | $2.4M | Sell |
189,069
-7,839
| -4% | -$99.4K | ﹤0.01% | 3095 |
|
|
2014
Q2 | $3.95M | Buy |
+196,908
| New | +$3.95M | ﹤0.01% | 2961 |
|